Iranian Society of Gynecology Oncology


Department of Obstetrics and Gynecology, Iran University of Medical Sciences, Tehran, IR Iran


  1. Solomon D, Nayar R. The Bethesda System for reporting cervical cytology: definitions, criteria, and explanatory notes. New York: Springer Science & Business Media; 2004. [DOI:10.1007/978-1-4612-2042-8]
  2. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197(4):346-55. [DOI:10.1016/j.ajog.2007.07.050]
  3. Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Ronald D. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions[U+202F]: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Int J Gyneco logical Pathol. 2012:76-115. [DOI:10.1097/LGT.0b013e31825c31dd]
  4. Aminimoghaddam S, Shadman L, Hashemi RS, Mohammadi Z, Mahmoudzadeh F. Sentinel lymph node detection using methylene blue in iranian patients with early stage cervical cancer. J Applied Sci. 2015;15(3):582. [DOI:10.3923/jas.2015.582.587]
  5. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol. 2013;121(4):829-46. [DOI:10.1097/AOG.0b013e3182883a34]